National and Kapodistrian University of Athens
Διαφοροποίηση των δεικτών αρτηριακής σκληρίας σε ασθενείς με πρωτοπαθή αρτηριακή υπέρταση και μεταβολικό σύνδρομο ανάλογα με την εκτροπή του μεταβολισμού του σακχάρου
Abstract
dc:descriptionIntroduction. Metabolic syndrome (MS) is associated with adverse cardiovascular events, although its prognostic significance over and beyond the clustering risk factors is controversial. Moreover, there are no data on the possible differentiation of target organ damage among patients with MS according to the grade of its distinct components. Methods. We studied 500 hypertensive patients with MS and we assessed vascular damage, according to glucose metabolic status (1. normal glucose metabolism, 2. IFG, 3. IGT and 4. DM II). Macrovascular damage was assessed with arterial stiffness, by measuring carotid-femoral pulse wave velocity (PWV). Wave reflections were also evaluated by measuring the augmentation index (AIx75). Microvascular damage was assessed with albumin excretion, by estimating the albumin-creatinine ratio (ACR). Results. There was a significant progressive increase in PWV from group 1 to group 4 (from 7.97 to 8.83 to 8.94 to 10.27 m/s, respectively) which remained statistically significant even after adjustment for several confounders (P<0.001). Similar trends were also observed for ACR (from 27.44 to 29.94 to 36.26 to 73.07 mg/g, P<0.001). AIx75 was increased from patients with NG to DMII, but without statistically significant difference between NG and IFG patients (from 25.38±10.54 to 25.95±9.22 to 28.09±7.83 to 30.83±7.08 %, p<0.05). In multiple regression analysis, both PWV and ACR were independently related to glucose metabolic status (P=0.001 and P<0.001, respectively) but such a relationship was not established for AIx75 (p=NS).Conclusions. Vascular alterations among patients with MS differ according to the grade of glucose dysregulation. Considering the adverse prognostic role of arterial stiffness and microalbuminuria, it might be argued that the cardiovascular risk is not homogenously spread among patients with MS, but, it is largely determined by the glucose metabolic status.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pietri, Panagiota
- Πιέτρη, Παναγιώτα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39586